Viyash Scientific share news and announcements
NSE: VIYASHBSE: 512529Pharmaceuticals & BiotechnologySmall Cap
Formerly Sequent Scientific
Last close ₹204.18down ₹3.81 (1.83%)BSE ₹203.45
Share price at the NSE close on 23 Oct 2026. Previous close ₹207.99.
52-week range of traded prices to 23 Oct 2026
₹178.13Low, 23 Mar 2026₹298.00High, 6 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹9,017 Cr598th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 May 2026
- 3.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 11.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 May 2026
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 44,68,18350.3% delivered
Viyash Scientific share news and announcements
593 announcements, routine notices left out, newest first. Page 10 of 12.
Aug 2019
Jul 2019
31 Jul · Board meeting
18 Jul · Legal
Exchange has sought clarification from Sequent Scientific Limited with respect to announcement dated 05-Jul-2019, regarding the Company has appointed and designated Mr. Tushar Mistry, Chief Financial Officer as Compliance Officer till the time the vacancy of Company Secretary is filled by the Company. On basis of above the Company is required to clarify following: 1. Date of appointment of Mr. Tushar Mistry. The response of the Company is awaited.5 Jul · Change in Company Secretary/Compliance Officer
1 Jul · Rating
Jun 2019
13 Jun · Legal
Exchange has sought clarification from Sequent Scientific Limited with respect to announcement dated 14-May-2019, regarding Change in Auditors of the company.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment)The response of the Company is awaited.
May 2019
30 May · Related Party Transactions
16 May · Results
15 May · Results
14 May · Management
Apr 2019
Mar 2019
Feb 2019
1 Feb · Board meeting
Jan 2019
Dec 2018
Nov 2018
2 Nov · Board meeting
Oct 2018
Sep 2018